{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:44:39Z","timestamp":1767869079892,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,22]],"date-time":"2015-01-22T00:00:00Z","timestamp":1421884800000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.vaccine.2014.10.070","type":"journal-article","created":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T11:56:35Z","timestamp":1415274995000},"page":"187-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean"],"prefix":"10.1016","volume":"33","author":[{"given":"A.M.","family":"Ropero-\u00c1lvarez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Whittembury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bravo-Alc\u00e1ntara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.J.","family":"Kurtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.C.","family":"Danovaro-Holliday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Velandia-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.10.070_bib0005","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/1471-2458-9-361","article-title":"Expansion of seasonal influenza vaccination in the Americas","volume":"9","author":"Ropero-Alvarez","year":"2009","journal-title":"BMC Public Health"},{"issue":"July","key":"10.1016\/j.vaccine.2014.10.070_bib0010","article-title":"Technical advisory group on vaccine-preventable diseases","author":"Pan American Health Organization","year":"2013","journal-title":"Seas Influenza Vaccin"},{"key":"10.1016\/j.vaccine.2014.10.070_bib0015","series-title":"Vacunaci\u00f3n Segura. M\u00f3dulos de Capacitaci\u00f3n. M\u00f3dulo VI. Sistema de monitoreo de los eventos supuestamente atribuibles a la vacunaci\u00f3n o inmunizaci\u00f3n (ESAVI)","author":"Organizaci\u00f3n Panamericana de la Salud","year":"2007"},{"key":"10.1016\/j.vaccine.2014.10.070_bib0020","first-page":"61","article-title":"Safety of rotavirus vaccines: postmarketing surveillance in the WHO Region of the Americas","volume":"86","author":"World Health Organization","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2014.10.070_bib0025","series-title":"World now at the start of influenza pandemic","author":"Chan","year":"2009"},{"issue":"15","key":"10.1016\/j.vaccine.2014.10.070_bib0030","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.vaccine.2009.01.125","article-title":"Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring","volume":"27","author":"Vellozzi","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2014.10.070_bib0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"issue":"9","key":"10.1016\/j.vaccine.2014.10.070_bib0040","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1177\/014107687907200908","article-title":"Guillain-Barr\u00e9 syndrome: the swine influenza virus vaccine incident in the United States of America, 1976\u201377: preliminary communication","volume":"72","author":"Langmuir","year":"1979","journal-title":"J R Soc Med"},{"key":"10.1016\/j.vaccine.2014.10.070_bib0045","series-title":"WHO pandemic influenza A (H1N1) vaccine deployment initiative: main operational lessons learned. Geneva, Switzerland","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.vaccine.2014.10.070_bib0050","series-title":"Immunization Safety. How to address events supposedly attributable to vaccination or immunization?","author":"Pan American Health Organization","year":"2002"},{"issue":"3","key":"10.1016\/j.vaccine.2014.10.070_bib0055","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1586\/14760584.7.3.345","article-title":"Rotavirus vaccine introduction in the Americas: progress and lessons learned","volume":"7","author":"de Oliveira LH1","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2014.10.070_bib0060","series-title":"Surveillance of events supposedly attributable to vaccination or immunization (ESAVI) linked to the pandemic influenza (H1N1) 2009 vaccine and crisis prevention: field guide","author":"Pan American Health Organization","year":"2010"},{"key":"10.1016\/j.vaccine.2014.10.070_bib0065","unstructured":"Pan American Health Organization. Technical Advisory Group on Vaccine-Preventable Diseases. Final Recommendations on Pandemic Influenza; 26 August 2009. Available at: http:\/\/www.paho.org\/english\/ad\/fch\/im\/PandemicFlu_TAGReco_Aug2009_e.pdf [last accessed 09.04.14]."},{"key":"10.1016\/j.vaccine.2014.10.070_bib0070","unstructured":"Brighton Collaboration. Immunize Safely. [last accessed 09.04.14]."},{"key":"10.1016\/j.vaccine.2014.10.070_bib0075","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barr\u00e9 syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.vaccine.2014.10.070_bib0080","first-page":"271","article-title":"Global Advisory Committee on vaccine safety, June 2012","volume":"30","author":"World Health Organization","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"issue":"Sep\u2013Dec (3)","key":"10.1016\/j.vaccine.2014.10.070_bib0085","first-page":"231","article-title":"Active surveillance of adverse effects of Pandemrix vaccine to prevent influenza A(H1N1) in Cuba","volume":"63","author":"Galindo Santana","year":"2011","journal-title":"Rev Cubana Med Trop."},{"issue":"5","key":"10.1016\/j.vaccine.2014.10.070_bib0090","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.vaccine.2011.11.092","article-title":"Pandemic influenza vaccination: lessons learned from Latin America and the Caribbean","volume":"30","author":"Ropero-\u00c1lvarez","year":"2012","journal-title":"Vaccine"},{"issue":"26","key":"10.1016\/j.vaccine.2014.10.070_bib0095","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1016\/j.vaccine.2011.04.005","article-title":"Safety monitoring of Influenza A\/H1N1 pandemic vaccines in EudraVigilance","volume":"29","author":"Kurz","year":"2011","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.vaccine.2014.10.070_bib0100","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1016\/j.vaccine.2010.09.021","article-title":"Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009\u2013January 31, 2010","volume":"28","author":"Vellozzi","year":"2010","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2014.10.070_bib0105","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa1008553","article-title":"Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China","volume":"364","author":"Liang","year":"2011","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.vaccine.2014.10.070_bib0110","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.vaccine.2009.01.125","article-title":"Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring","volume":"27","author":"Vellozzi","year":"2009","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2014.10.070_bib0115","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4161\/hv.7.5.14821","article-title":"Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinations","volume":"7","author":"Banzhoff","year":"2011","journal-title":"Hum Vaccin"},{"issue":"7","key":"10.1016\/j.vaccine.2014.10.070_bib0120","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.arcmed.2011.10.007","article-title":"Events temporarily associated with anti-influenza A (H1N1) vaccination in Mexico","volume":"42","author":"Vidal","year":"2011","journal-title":"Arch Med Res"},{"issue":"3","key":"10.1016\/j.vaccine.2014.10.070_bib0125","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.vaccine.2010.10.067","article-title":"Adverse events associated with pandemic influenza vaccines: comparison of the results of a follow-up study with those coming from spontaneous reporting","volume":"29","author":"Carvajal","year":"2011","journal-title":"Vaccine"},{"issue":"Nov (5)","key":"10.1016\/j.vaccine.2014.10.070_bib0130","doi-asserted-by":"crossref","first-page":"473.e1","DOI":"10.1016\/j.ajog.2011.06.047","article-title":"Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System","volume":"205","author":"Moro","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.vaccine.2014.10.070_bib0135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7883\/yoken.64.297","article-title":"Active surveillance of adverse events following immunization against pandemic influenza A (H1N1) in Korea","volume":"64","author":"Choe","year":"2011","journal-title":"Jpn J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2014.10.070_bib0140","doi-asserted-by":"crossref","first-page":"e23049","DOI":"10.1371\/journal.pone.0023049","article-title":"Adverse events following pandemic A (H1N1) 2009 monovalent vaccines in pregnant women\u2014Taiwan, November 2009\u2013August 2010","volume":"6","author":"Huang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.10.070_bib0145","doi-asserted-by":"crossref","first-page":"e2794","DOI":"10.1136\/bmj.e2794","article-title":"Vaccination against pandemic A\/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark","volume":"344","author":"Pasternak","year":"2012","journal-title":"BMJ"},{"issue":"52","key":"10.1016\/j.vaccine.2014.10.070_bib0150","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1016\/j.vaccine.2011.10.034","article-title":"Non-adjuvanted 2009 influenza A (H1N1)v vaccine in pregnant women: the results of a French prospective descriptive study","volume":"29","author":"Omon","year":"2011","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.vaccine.2014.10.070_bib0155","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1016\/j.vaccine.2013.05.027","article-title":"Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness of new high priority vaccines","volume":"31","author":"Izurieta","year":"2013","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14014601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14014601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T12:38:02Z","timestamp":1650544682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14014601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0264410X14014601"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.10.070","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.10.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}